Human Milk Oligosaccharides Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Distribution Channel, and Region

Description

List of Tables

The global human milk oligosaccharides market size is expected to reach USD 1,821.29 million by 2034, according to a new study by Polaris Market Research. The report "Human Milk Oligosaccharides (HMO) Market Size, Share, Trends, Industry Analysis Report: By Type (2'FL, 3'FL, 3'SL, and 6'SL), Application, Distribution Channel, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034," gives a detailed insight into current market dynamics and provides analysis on future market growth.

The human milk oligosaccharides market growth is driven by the increasing awareness related to the health benefits of human milk oligosaccharides (HMO), particularly in infant nutrition. Human milk oligosaccharides are bioactive carbohydrates naturally found in human breast milk that play a crucial role in supporting infant gut health, immunity, and cognitive development. By acting as prebiotics, HMO promotes the growth of beneficial gut bacteria, protects against harmful pathogens, and enhances overall digestive health. Moreover, with the growing global population and rising number of working mothers, there is an increasing demand for infant formulas enriched with human milk oligosaccharides (HMO). As these products aim to replicate the nutritional and health benefits of breast milk, their demand is projected to increase during the forecast period. Furthermore, advancements in fermentation-based production technologies have made human milk oligosaccharides (HMO) more accessible, enabling their integration into functional foods, dietary supplements, and pharmaceutical applications.

The human milk oligosaccharides market trends reflect its expanding adoption beyond infant nutrition. Increasing consumer interest in gut health and immunity, coupled with the rising demand for bioactive ingredients in functional foods, has driven the incorporation of HMO into adult supplements and health products. Personalized nutrition is also gaining traction, with human milk oligosaccharides (HMO)-based formulations tailored to individual health needs. Additionally, clean-label and plant-based trends are encouraging the development of sustainable and ethically sourced HMO products. As companies continue to perform research to discover new applications for human milk oligosaccharides (HMO) and validate their benefits, the market is expected to grow during the forecast period, supported by strategic collaborations and innovative product launches by key industry players. Therefore, human milk oligosaccharides perform as a dynamic and rapidly evolving market in the global health and wellness industry.

One of the key factors promoting the market expansion of HMOs includes improvement in production techniques. For instance, advancements in synthetic biology and metabolic engineering have improved microbial systems, such as Escherichia coli, which is used to produce HMO. Moreover, techniques such as chemoenzymatic synthesis have become a viable alternative to conventional chemical methods for producing natural products. Therefore, improvements in technology and the improved ability of the manufacturers to produce HMO help improve yields and reduce costs.

Human Milk Oligosaccharides Market Report Highlights

Based on type, the 2'FL segment led the HMO market share in 2024, representing 54.16% of revenue. Its high demand is attributed to its significant health benefits, particularly in infant nutrition.
The human milk oligosaccharides market, by distribution channel, is segmented into hypermarkets & supermarkets, drug store or pharmacy, online sales channel, and others. The hypermarkets & supermarkets play a crucial role in the distribution of human milk oligosaccharides (HMO)-enriched products due to their widespread presence, high foot traffic, and ability to offer a diverse range of products.
In 2024, Asia Pacific dominated the human milk oligosaccharides market revenue share, primarily fueled by the region's expanding population and rising birth rates, especially in countries such as China and India.
A few global key market players are Elicityl S.A., Abbott Laboratories, Biosynth Carbosynth, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Glycosyn, BASF S.E., Glycom A/S, Nestle Health Science, Neolacta Lifesciences Pvt. Ltd., Royal DSM, Medolac Laboratories, Chr. Hansen Holding A/S, ZuChem, Inbiose NV, and Royal FrieslandCampina N.V.

Polaris Market Research has segmented the human milk oligosaccharides (HMO) market report on the basis of type, application, distribution channel, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

2'FL
3'FL
3'SL
6'SL

By Application Outlook (Revenue - USD Million, 2020-2034)

Infant Formula
Functional Food & Beverage
Food Supplements

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

Hypermarkets & Supermarkets
Drug Store or Pharmacy
Online Sales Channel
Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Australia
Malaysia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

Product Code: PM2516

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Human Milk Oligosaccharides (HMO) Market Insights

4.1. Human Milk Oligosaccharides (HMO) Market - Distribution Channel Snapshot
4.2. Human Milk Oligosaccharides (HMO) Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Demand for Infant Nutrition
  - 4.2.1.2. Rising Prebiotic and Probiotic Demand
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Initial Investment
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Human Milk Oligosaccharides (HMO) Market Trends
4.6. Value Chain Analysis

5. Global Human Milk Oligosaccharides (HMO) Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
5.3. 2'FL
- 5.3.1. Global Human Milk Oligosaccharides (HMO) Market, by 2'FL, by Region, 2020-2034 (USD Million)
5.4. 3'FL
- 5.4.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'FL, by Region, 2020-2034 (USD Million)
5.5. 3'SL
- 5.5.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'SL, by Region, 2020-2034 (USD Million)
5.6. 6'SL
- 5.6.1. Global Human Milk Oligosaccharides (HMO) Market, by 6'SL, by Region, 2020-2034 (USD Million)

6. Global Human Milk Oligosaccharides (HMO) Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
6.3. Infant Formula
- 6.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Infant Formula, by Region, 2020-2034 (USD Million)
6.4. Functional Food & Beverage
- 6.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Functional Food & Beverage, by Region, 2020-2034 (USD Million)
6.5. Food Supplements
- 6.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Food Supplements, by Region, 2020-2034 (USD Million)

7. Global Human Milk Oligosaccharides (HMO) Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
7.3. Hypermarkets & Supermarkets
- 7.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Hypermarkets & Supermarkets, by Region, 2020-2034 (USD Million)
7.4. Drug Store or Pharmacy
- 7.4.1. Global Human Milk Oligosaccharides (HMO) Market, Drug Store or Pharmacy, by Region, 2020-2034 (USD Million)
7.5. Online Sales Channel
- 7.5.1. Global Human Milk Oligosaccharides (HMO) Market, Online Sales Channel, by Region, 2020-2034 (USD Million)
7.6. Others
- 7.6.1. Global Human Milk Oligosaccharides (HMO) Market, Others, by Region, 2020-2034 (USD Million)

8. Global Human Milk Oligosaccharides (HMO) Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Human Milk Oligosaccharides (HMO) Market - North America
- 8.3.1. North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
- 8.3.2. North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
- 8.3.3. North America: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.5. Human Milk Oligosaccharides (HMO) Market - U.S.
  - 8.3.5.1. U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.3.5.2. U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.3.5.3. U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.6. Human Milk Oligosaccharides (HMO) Market - Canada
  - 8.3.6.1. Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.3.6.2. Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.3.6.3. Canada: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
8.4. Human Milk Oligosaccharides (HMO) Market - Europe
- 8.4.1. Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
- 8.4.3. Europe: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.4. Human Milk Oligosaccharides (HMO) Market - UK
  - 8.4.4.1. UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
  - 8.4.4.4. UK: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.5. Human Milk Oligosaccharides (HMO) Market - France
  - 8.4.5.1. France: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.4.5.2. France: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.4.5.3. France: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.6. Human Milk Oligosaccharides (HMO) Market - Germany
  - 8.4.6.1. Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.7. Human Milk Oligosaccharides (HMO) Market - Italy
  - 8.4.7.1. Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.8. Human Milk Oligosaccharides (HMO) Market - Spain
  - 8.4.8.1. Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.9. Human Milk Oligosaccharides (HMO) Market - Netherlands
  - 8.4.9.1. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.10. Human Milk Oligosaccharides (HMO) Market - Russia
  - 8.4.10.1. Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.11. Human Milk Oligosaccharides (HMO) Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
8.5. Human Milk Oligosaccharides (HMO) Market - Asia Pacific
- 8.5.1. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.4. Human Milk Oligosaccharides (HMO) Market - China
  - 8.5.4.1. China: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.5.4.2. China: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.5.4.3. China: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.5. Human Milk Oligosaccharides (HMO) Market - India
  - 8.5.5.1. India: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.5.5.2. India: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.5.5.3. India: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.6. Human Milk Oligosaccharides (HMO) Market - Malaysia
  - 8.5.6.1. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.7. Human Milk Oligosaccharides (HMO) Market - Japan
  - 8.5.7.1. Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.8. Human Milk Oligosaccharides (HMO) Market - Indonesia
  - 8.5.8.1. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.9. Human Milk Oligosaccharides (HMO) Market - South Korea
  - 8.5.9.1. South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.10. Human Milk Oligosaccharides (HMO) Market - Australia
  - 8.5.10.1. Australia: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.11. Human Milk Oligosaccharides (HMO) Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
8.6. Human Milk Oligosaccharides (HMO) Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.4. Human Milk Oligosaccharides (HMO) Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.5. Human Milk Oligosaccharides (HMO) Market - UAE
  - 8.6.5.1. UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.6. Human Milk Oligosaccharides (HMO) Market - Israel
  - 8.6.6.1. Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.7. Human Milk Oligosaccharides (HMO) Market - South Africa
  - 8.6.7.1. South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.8. Human Milk Oligosaccharides (HMO) Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
8.7. Human Milk Oligosaccharides (HMO) Market - Latin America
- 8.7.1. Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
- 8.7.3. Latin America: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.4. Human Milk Oligosaccharides (HMO) Market - Mexico
  - 8.7.4.1. Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.5. Human Milk Oligosaccharides (HMO) Market - Brazil
  - 8.7.5.1. Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.6. Human Milk Oligosaccharides (HMO) Market - Argentina
  - 8.7.6.1. Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.7. Human Milk Oligosaccharides (HMO) Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Human Milk Oligosaccharides (HMO) Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. BASF S.E.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Biosynth Carbosynth
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Chr. Hansen Holding A/S
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Dextra Laboratories Ltd.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Dupont Nutrition & Biosciences
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Elicityl S.A.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Glycosyn
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Inbiose NV
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Medolac Laboratories
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Neolacta Lifesciences Pvt. Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Nestle Health Science
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Royal DSM
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Royal FrieslandCampina N.V.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. ZuChem
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development